Cargando…
High content screening for drug discovery from traditional Chinese medicine
Traditional Chinese medicine (TCM) represents the crystallization of Chinese wisdom and civilization. It has been valued as the renewable source for the discovery of novel drugs, owing to its long-term proved efficacy in human diseases and abundant biologically active components pools. To dissect th...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394041/ https://www.ncbi.nlm.nih.gov/pubmed/30858873 http://dx.doi.org/10.1186/s13020-019-0228-y |
_version_ | 1783398811963490304 |
---|---|
author | Wang, Jing Wu, Ming-Yue Tan, Jie-Qiong Li, Min Lu, Jia-Hong |
author_facet | Wang, Jing Wu, Ming-Yue Tan, Jie-Qiong Li, Min Lu, Jia-Hong |
author_sort | Wang, Jing |
collection | PubMed |
description | Traditional Chinese medicine (TCM) represents the crystallization of Chinese wisdom and civilization. It has been valued as the renewable source for the discovery of novel drugs, owing to its long-term proved efficacy in human diseases and abundant biologically active components pools. To dissect the mystery of TCM, modern technologies such as omics approaches (proteomics, genomics, metabolomics) and drug screening technologies (high through-put screening, high content screening and virtual screening) have been widely applied to either identify the drug target of TCM or identify the active component with certain bio-activity. The advent of high content screening technology has absolutely contributed to a breakthrough in compounds discovery and influenced the evolution of technology in screening field. The review introduces the concept and principle of high content screening, lists and compares the currently used HCS instruments, and summarizes the examples from ours and others research work which applied HCS in TCM-derived compounds screening. Meanwhile, this article also discusses the advantages and limitations of HSC technology in drug discovery from TCM libraries. |
format | Online Article Text |
id | pubmed-6394041 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-63940412019-03-11 High content screening for drug discovery from traditional Chinese medicine Wang, Jing Wu, Ming-Yue Tan, Jie-Qiong Li, Min Lu, Jia-Hong Chin Med Review Traditional Chinese medicine (TCM) represents the crystallization of Chinese wisdom and civilization. It has been valued as the renewable source for the discovery of novel drugs, owing to its long-term proved efficacy in human diseases and abundant biologically active components pools. To dissect the mystery of TCM, modern technologies such as omics approaches (proteomics, genomics, metabolomics) and drug screening technologies (high through-put screening, high content screening and virtual screening) have been widely applied to either identify the drug target of TCM or identify the active component with certain bio-activity. The advent of high content screening technology has absolutely contributed to a breakthrough in compounds discovery and influenced the evolution of technology in screening field. The review introduces the concept and principle of high content screening, lists and compares the currently used HCS instruments, and summarizes the examples from ours and others research work which applied HCS in TCM-derived compounds screening. Meanwhile, this article also discusses the advantages and limitations of HSC technology in drug discovery from TCM libraries. BioMed Central 2019-02-28 /pmc/articles/PMC6394041/ /pubmed/30858873 http://dx.doi.org/10.1186/s13020-019-0228-y Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Review Wang, Jing Wu, Ming-Yue Tan, Jie-Qiong Li, Min Lu, Jia-Hong High content screening for drug discovery from traditional Chinese medicine |
title | High content screening for drug discovery from traditional Chinese medicine |
title_full | High content screening for drug discovery from traditional Chinese medicine |
title_fullStr | High content screening for drug discovery from traditional Chinese medicine |
title_full_unstemmed | High content screening for drug discovery from traditional Chinese medicine |
title_short | High content screening for drug discovery from traditional Chinese medicine |
title_sort | high content screening for drug discovery from traditional chinese medicine |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394041/ https://www.ncbi.nlm.nih.gov/pubmed/30858873 http://dx.doi.org/10.1186/s13020-019-0228-y |
work_keys_str_mv | AT wangjing highcontentscreeningfordrugdiscoveryfromtraditionalchinesemedicine AT wumingyue highcontentscreeningfordrugdiscoveryfromtraditionalchinesemedicine AT tanjieqiong highcontentscreeningfordrugdiscoveryfromtraditionalchinesemedicine AT limin highcontentscreeningfordrugdiscoveryfromtraditionalchinesemedicine AT lujiahong highcontentscreeningfordrugdiscoveryfromtraditionalchinesemedicine |